Search Results

Agricola

Record details

Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis.

• Authors : Oh, SuA; Purja, Sujata; Shin, Hocheol

Subjects: HYPOGLYCEMIC agents; TYPE 2 diabetes; GLUCAGON-like peptide 1

• Source: Diabetes & Vascular Disease Research; May/Jun2022, Vol. 19 Issue 3, p1-14, 14p

Record details

CITATIONS AND CLINICIANS' NOTES: MANAGEMENT -- ORAL HYPOGLYCEMIC AGENTS.

Subjects: *ORAL therapy for diabetes; *ORAL drug administration; *INSULIN

• Source: Current Medical Literature: Diabetes. 2004, Vol. 21 Issue 3, p91-92. 2p.

Record details

Rational design and biological evaluation of gemfibrozil modified Xenopus GLP-1 derivatives as long-acting hypoglycemic agents.

• Authors : Han J; Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, PR China; School of Chemistry and Materials Science, Jiangsu Normal University, Xuzhou, 221116, PR China.

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Gemfibrozil/Gemfibrozil/Gemfibrozil/*chemistry ; Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/*chemistry

• Source: European journal of medicinal chemistry [Eur J Med Chem] 2020 Jul 15; Vol. 198, pp. 112389. Date of Electronic Publication: 2020 May 04.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Design, synthesis and biological evaluation of PEGylated Xenopus glucagon-like peptide-1 derivatives as long-acting hypoglycemic agents.

• Authors : Han J; School of Chemistry and Chemical Engineering, Jiangsu Key Laboratory of Green Synthetic Chemistry for Functional Materials, Jiangsu Normal University, Xuzhou 221116, PR China. Electronic address: .; Wang Y

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/*chemistry ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*chemical synthesis

• Source: European journal of medicinal chemistry [Eur J Med Chem] 2017 May 26; Vol. 132, pp. 81-89. Date of Electronic Publication: 2017 Mar 18.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Efficacy and safety comparison of add-on therapy with liraglutide, saxagliptin and vildagliptin, all in combination with current conventional oral hypoglycemic agents therapy in poorly controlled Chinese type 2 diabetes.

• Authors : Li CJ; Department of Endocrinology, 2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Key Laboratory of Hormone and Development (Ministry of Health), Metabolic Disease Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, China.; Yu Q

Subjects: Adamantane/Adamantane/Adamantane/*analogs & derivatives ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptides/Dipeptides/Dipeptides/*therapeutic use

• Source: Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association [Exp Clin Endocrinol Diabetes] 2014 Sep; Vol. 122 Publisher: J.A. Barth Country of Publication: Germany NLM ID: 9505926 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-3646

Record details